Bio-Technology General Euflexxa 1% Sodium Hyaluronate

Država: Singapur

Jezik: engleski

Izvor: HSA (Health Sciences Authority)

Dostupno od:

FERRING PHARMACEUTICALS PRIVATE LIMITED

Razred:

Class D medical device

Proizveden od:

Bio-Technology General (Israel) Ltd.

Područje terapije:

Orthopaedics

Terapijske indikacije:

EUFLEXXA is indicated for the treatment of pain caused by osteoarthritis of the knee, hip, temporomandibular, carpometacarpal, shoulder and ankle joints. EUFLEXXA aids in lubrication of the joint, allows for greater mobility and flexibility of the treated joint, and reduces pain in the affected joint.

Proizvod sažetak:

Device System Info:[Sterile Medical Device], EUFLEXXA is packed in a single-use, aseptically-filled disposable sterile 2.25 ml syringe (nominal volume) containing either 1 ml or 2 ml of 1% microbial fermentation-derived NaHA in phosphate-buffered saline; Models: Euflexxa 1% Sodium Hyaluronate - 3 x 2ml, Euflexxa 1% Sodium Hyaluronate - 1 x 2ml

Datum autorizacije:

2017-04-28